Image 1
Chemical structure of Tolterodine Tartrate, showing the molecular arrangement of the active ingredient and its tartaric acid salt component.*
Tolterodine Tartrate Capsule, Extended Release
Product Images NDC 0093-7164
3 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tolterodine Tartrate (NDC 0093-7164). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Label for Tolterodine Tartrate Extended-Release Capsules 2 mg, a drug for further processing, from Teva Pharmaceuticals USA, Inc. The label indicates a package of 30 capsules. It includes storage instructions, manufacturer details (Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals Industries Ltd.), a barcode, and NDC 0093-7163-56. The label has a white background with maroon and red text and graphics.*
Image 3
Label for Tolterodine Tartrate Extended-Release Capsules, 4 mg, by Teva Pharmaceuticals USA, Inc. The label indicates 30 capsules per container and includes storage instructions, manufacturer information, and a barcode. The product is prescription only.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
